NCT06818630View on ClinicalTrials.gov

Enhanced Photoaging Reversal Efficacy and Safety of 755nm Alexandrite Picosecond Laser with Diffractive Lens Array (DLA) in Conjunction with Integrated Skin Care for Skin Quality Improvement

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 29, 2024

Primary Completion Date

October 29, 2024

Study Completion Date

January 23, 2025

Conditions

Skin Quality Improvement

Interventions

OTHER

SkinCeuticals combination skin care products

"1. CE Ferulic Serum,~2. Discoloration Defense (3% Tranexamic Acid),~3. Triple Lipid Restore 2:4:2"

OTHER

Regular skin care procedure

"1. Regular moisturizing product (Phyto Corrective Gel),~2. sunscreen (Advanced Brightening UV Defense SPF50 PA++++)"

Trial Locations (1)

300

Bright Skin Clinic, Hsinchu

All Listed Sponsors

lead

L'Oréal Taiwan Co., Ltd

INDUSTRY

NCT06818630 - Enhanced Photoaging Reversal Efficacy and Safety of 755nm Alexandrite Picosecond Laser with Diffractive Lens Array (DLA) in Conjunction with Integrated Skin Care for Skin Quality Improvement | Biotech Hunter | Biotech Hunter